Journal
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
Volume 23, Issue 1, Pages 23-33Publisher
WILEY-BLACKWELL
DOI: 10.1111/j.1440-1746.2007.05117.x
Keywords
adenocarcinoma; endoscopic ultrasound; multidetector computed tomography; pancreas; positron emission tomography; computed tomography
Categories
Ask authors/readers for more resources
Pancreatic adenocarcinoma is one of the leading causes of cancer death in the West, with a poor overall 5-year survival rate of only 4%. Late clinical presentation with an advanced disease results in a low rate of surgical intervention. Tumor serum marker CA 19-9 is sensitive, although not specific for the diagnosis of adenocarcinomas of the pancreas. The treatment approach is based on whether the tumor is resectable or non-resectable at presentation. Therefore, imaging plays a crucial role in the management of this disease. Many modalities are available to image the pancreas. They include non-invasive techniques, like ultrasound, contrast-enhanced multidetector computed tomography, magnetic resonance imaging and integrated positron emission tomography/computed tomography, and invasive techniques, like endoscopic retrograde cholangiopancreatography and endoscopic ultrasound. Each of these modalities has its peculiar strengths and weaknesses.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available